MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia
Open Access
- 19 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 20 (1), 1-15
- https://doi.org/10.1186/s12885-020-06749-w
Abstract
Background Despite conflicting results, considerable evidence suggests the association between single nucleotide polymorphisms in MTHFR, XRCC1 and OGG1 genes and, risk of developing breast cancer. Here a case-control study is reported, including 135 breat cancer patients and 112 healthy women, all representative of Northern Sardinian population. Methods Polymerase chain reaction/restriction fragment length polymorphism method was used to determine the genotypes of five polymorphisms: MTHFR C677T (rs1801133) and A1298C (rs1801131), XRCC1 Arg194Trp (rs1799782) and Arg399Gln (rs25487) and OGG1 Ser326Cys (rs1052133). Allelic, genotypic and haplotype association analyses with disease risk and clinicopathological parameters were performed. Results A nominally significant association with breast cancer risk was observed for MTHFR C677T polymorphism heterozygous genotype in the codominant model (OR: 0.57, 95% CI: 0.32-1.00, p = 0.049) and for Cys/Cys genotype of the OGG1 Ser326Cys polymorphism in the recessive model (OR: 0.23, 95% CI: 0.05-1.11, p = 0.0465). No significant differences were found at genotype-level for A1298C polymorphism of the MTHFR gene and Arg194Trp and Arg399Gln of the XRCC1 gene. Furthermore, the OGG1 and XRCC1 rs25487 polymorphisms were nominally associated with PgR, Her2 status and with sporadic breast cancer, respectively. Conclusions Based on genetic characteristics of individuals included in this study, results suggest that MTHFR CT and OGG1 Cys/Cys genotypes have a protective effect that may have an influence on breast cancer risk in a representative Northern Sardinian population.Funding Information
- Fondazione di Sardegna, Bando “Salute Pubblica, Medicina Preventiva e Riabilitativa“, Anno 2018. (U408.2019/AI.373.PL)
This publication has 92 references indexed in Scilit:
- Effector CD4 and CD8 T Cells and Their Role in the Tumor MicroenvironmentCancer Microenvironment, 2012
- MTHFR polymorphisms and breast cancer riskVideosurgery and Other Miniinvasive Techniques, 2011
- Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian womenZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patientsMutation research. Reviews in mutation research, 2008
- Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysisBreast Cancer Research and Treatment, 2007
- Allaitement maternel et cancer du seinGynécologie Obstétrique & Fertilité, 2005
- Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrationsMutation research. Reviews in mutation research, 2004
- Reduced breast cancer risk with increasing serum folate in a case–control study of the C677T genotype of the methylenetetrahydrofolate reductase geneEuropean Journal of Cancer, 2004
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995